- Q1 88 %56.1
- Q2 44 %28.0
- Q3 23 %14.6
- Q4 2 %1.3
Academician
ÖZDEN ALTUNDAĞ
PROFESÖR
BAŞKENT ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Endometrial and Cervical Cancer Treatments19
- Lung Cancer Treatments and Mutations17
- Cancer Treatment and Pharmacology16
- Estrogen and related hormone effects14
- HER2/EGFR in Cancer Research13
- Breast Cancer Treatment Studies12
- Ovarian cancer diagnosis and treatment12
- Lung Cancer Diagnosis and Treatment10
- Uterine Myomas and Treatments10
- Bone health and treatments9
- Lung Cancer Research Studies9
- Cancer Risks and Factors8
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 147- i10-index
- 32
- Total citations
- 16,120 Top 0.1% in Türkiye
- Per article
- 109.7
- FWCI
- 6.46 1.00 = world average
- World top 1%
- 7
- World top 10%
- 12
Most cited articles
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.
Field ranking
YÖKSİS ?-
Main field Sağlık Bilimleri Temel AlanıPoints rank #204/ 43,834 top 0.5% At university #3/ 640Score 140.75 journal 140 · OA add 0.75
- Article rank613/43,834
- Scopus rank177/43,834
- WoS rank170/43,834
- YÖKSİS161
- Scopus157
- WoS159
-
Side field Tıbbi Onkoloji (İç Hastalıkları)Points rank #11/ 318 top 3.5% At university #1/ 9Score 140.75 journal 140 · OA add 0.75
- Article rank15/318
- Scopus rank10/318
- WoS rank10/318
- YÖKSİS161
- Scopus157
- WoS159
Index quartiles
?- Q1 56 %35.2
- Q2 28 %17.6
- Q3 27 %17.0
- Q4 48 %30.2
Other counts
Scopus (SJR)
- YÖKSİS rows 163
WoS (JCR)
- YÖKSİS rows 165
Proceedings
Conference proceedings recorded in YÖKSİS.
Records
-
2018 Kötü Histolojili Endometrium Kanserli Olgularda Yalnız Vajen Kaf Brakiterapisi Uygulamasının Sonuçları
-
2018 ESMO-ESGO-ESTRO Risk Gruplamasına Göre Endometrium Kanserli Olgularda Sağkalım ve Rekürrens Dağılımı
-
2018 Patterns of Recurrence and Survival Rates in Endometrial Cancer According to ESMO-ESGO-ESTRO Risk Classification.
-
2018 Patterns of Recurrence and Survival Rates in Endometrial Cancer According to ESMO-ESGO-ESTRO Risk Classification
-
2018 ESMO-ESGO-ESTRO Risk Gruplamasına Göre Endometrium Kanserli Olgularda Sağkalım ve Rekürrens Dağılımı
-
2018 Kötü Histolojili Endometrium Kanserli Olgularda Yalnız Vajen Kaf Brakiterapisi Uygulamasının Sonuçları
-
2018 ESMO-ESGO-ESTRO Risk Gruplamasına Göre Endometrium Kanserli Olgularda Sağkalım ve Rekürrens
-
2018 Kötü Histolojili Endometrium Kanserli Olgularda Yalnız Vajen Kaf Brakiterapisi Uygulamasının Sonuçlar
-
2018 Patterns of Recurrence and Survival Rates in Endometrial Cancer According to ESMO-ESGO-ESTRO Risk Classification
-
2018 Kötü histolojili endometrium kanserli olgularda yalnız vajen kaf brakiterapisi uygulamasının sonuçları